← Back to Clinical Trials
Recruiting NCT07465510

NCT07465510 Ultrasound vs. Auscultation and Fiberoptic Bronchoscopy for Double-Lumen Tube Placement

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07465510
Status Recruiting
Phase
Sponsor Izmir City Hospital
Condition Thoracic Surgery With One-lung Ventilation
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2026-01-25
Primary Completion 2026-05-25

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2026-01-25 with a primary completion date of 2026-05-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

One-lung ventilation is frequently required in thoracic surgery and is most commonly achieved using double-lumen endobronchial tubes (DLTs). Correct positioning of the DLT is crucial for effective lung isolation and patient safety. Fiberoptic bronchoscopy (FOB) is considered the gold standard for confirming DLT placement; however, it may not always be immediately available and requires specific expertise. Lung ultrasonography is a rapid, noninvasive, and bedside imaging method increasingly used in anesthesiology and critical care. This prospective observational study aims to evaluate the diagnostic performance of lung ultrasound in confirming the correct position of double-lumen endobronchial tubes in patients undergoing thoracic surgery. The results obtained from lung ultrasound will be compared with auscultation findings and fiberoptic bronchoscopy results. Fiberoptic bronchoscopy will be considered the reference standard. The sensitivity, specificity, positive predictive value, and negative predictive value of lung ultrasound and auscultation will be calculated.

Eligibility Criteria

Inclusion Criteria: * Age between 18 and 65 years * Scheduled for elective thoracic surgery * Planned one-lung ventilation * Use of double-lumen endobronchial tube * ASA physical status I-III * Written informed consent obtained Exclusion Criteria: * Known airway anomalies * Previous lung resection surgery * Tracheostomy * Coagulopathy * Pleural effusion or pleural pathology that may interfere with lung ultrasound evaluation * Chest wall deformity * Emergency surgery * Patients who decline participation

Contact & Investigator

Central Contact

Cansu KATKAY, M.D.

✉ cansu-katkay07@hotmail.com

📞 +905423847269

Frequently Asked Questions

Who can join the NCT07465510 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Thoracic Surgery With One-lung Ventilation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07465510 currently recruiting?

Yes, NCT07465510 is actively recruiting participants. Contact the research team at cansu-katkay07@hotmail.com for enrollment information.

Where is the NCT07465510 trial being conducted?

This trial is being conducted at Izmir, Turkey (Türkiye).

Who is sponsoring the NCT07465510 clinical trial?

NCT07465510 is sponsored by Izmir City Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology